Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria

Molecular Immunology

Volumn 46, Issue 7, 2009, Pages 1312-1318

  Koh, Kah Wee ^a   Lehming, Norbert ^a   Seah, Geok Teng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cytotoxic T cells; Domains; Mycobacteria; Proteasome; Protein; Ubiquitin

Indexed keywords

ALANINE; ASPARAGINE; BACTERIAL PROTEIN; CD8 ANTIGEN; GAMMA TUBULIN; GLUTAMIC ACID; GLYCINE; HYBRID PROTEIN; INTERLEUKIN 2; ISOLEUCINE; LEUCINE; LYSINE; PHENYLALANINE; PROTEASOME; PROTEIN PE PGRS; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENOME; CD8+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; CYTOLYSIS; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CELLS, CULTURED; CLONING, MOLECULAR; GREEN FLUORESCENT PROTEINS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS;

CORYNEBACTERINEAE; MUS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 62549109933     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.11.008     Document Type: Article

References (42)

1. Bachmair A., Finley D., and Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234 (1986) 179-186
2. Banu S., Honore N., Saint-Joanis B., Philpott D., Prevost M.C., and Cole S.T. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?. Mol. Microbiol. 44 (2002) 9-19
3. Beal R., Deveraux Q., Xia G., Rechsteiner M., and Pickart C. Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 861-866
4. Betts J.C., Lukey P.T., Robb L.C., McAdam R.A., and Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43 (2002) 717-731
5. Blake N., Lee S., Redchenko I., Thomas W., Steven N., Leese A., Steigerwald-Mullen P., Kurilla M.G., Frappier L., and Rickinson A. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7 (1997) 791-802
6. Brennan M.J., and Delogu G. The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbiol. 10 (2002) 246-249
7. Brennan M.J., Delogu G., Chen Y., Bardarov S., Kriakov J., Alavi M., and Jacobs Jr. W.R. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect. Immun. 69 (2001) 7326-7333
8. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
9. Cooper A.M., D'Souza C., Frank A.A., and Orme I.M. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65 (1997) 1317-1320
10. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., and Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178 (1993) 2243-2247
11. Dantuma N.P., Heessen S., Lindsten K., Jellne M., and Masucci M.G. Inhibition of proteasomal degradation by the Gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8381-8385
12. Dantuma N.P., Lindsten K., Glas R., Jellne M., and Masucci M.G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18 (2000) 538-543
13. Dillner J., Sternas L., Kallin B., Alexander H., Ehlin-Henriksson B., Jornvall H., Klein G., and Lerner R. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4652-4656
14. Falnes P.O., and Olsnes S. Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway. EMBO J. 17 (1998) 615-625
15. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
16. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., and Bloom B.R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 12013-12017
17. Gonda D.K., Bachmair A., Wunning I., Tobias J.W., Lane W.S., and Varshavsky A. Universality and structure of the N-end rule. J. Biol. Chem. 264 (1989) 16700-16712
18. Johnson E.S., Ma P.C., Ota I.M., and Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270 (1995) 17442-17456
19. Karboul A., Gey van Pittius N.C., Namouchi A., Vincent V., Sola C., Rastogi N., Suffys P., Fabre M., Cataldi A., Huard R.C., et al. Insights into the evolutionary history of tubercle bacilli as disclosed by genetic rearrangements within a PE_PGRS duplicated gene pair. BMC Evol. Biol. 6 (2006) 107
20. Karttunen J., Sanderson S., and Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6020-6024
21. Karttunen J., and Shastri N. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3972-3976
22. Lamichhane G., Zignol M., Blades N.J., Geiman D.E., Dougherty A., Grosset J., Broman K.W., and Bishai W.R. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7213-7218
23. Lee S.P., Brooks J.M., Al-Jarrah H., Thomas W.A., Haigh T.A., Taylor G.S., Humme S., Schepers A., Hammerschmidt W., Yates J.L., et al. CD8 T cell recognition of endogenously expressed Epstein-barr virus nuclear antigen 1. J. Exp. Med. 199 (2004) 1409-1420
24. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., and Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375 (1995) 685-688
25. Levitskaya J., Sharipo A., Leonchiks A., Ciechanover A., and Masucci M.G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 12616-12621
26. Masucci M.G., and Ernberg I. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol. 2 (1994) 125-130
27. Muller I., Cobbold S.P., Waldmann H., and Kaufmann S.H. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect. Immun. 55 (1987) 2037-2041
28. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., and Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335 (1996) 1941-1949
29. Orme I.M., and Collins F.M. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell. Immunol. 84 (1984) 113-120
30. Pathan A.A., Wilkinson K.A., Wilkinson R.J., Latif M., McShane H., Pasvol G., Hill A.V., and Lalvani A. High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur. J. Immunol. 30 (2000) 2713-2721
31. Ramakrishnan L., Federspiel N.A., and Falkow S. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288 (2000) 1436-1439
32. Rock K.L., and Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17 (1999) 739-779
33. Sharipo A., Imreh M., Leonchiks A., Branden C., and Masucci M.G. cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition. FEBS Lett. 499 (2001) 137-142
34. Sharipo A., Imreh M., Leonchiks A., Imreh S., and Masucci M.G. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat. Med. 4 (1998) 939-944
35. Shen Z., Reznikoff G., Dranoff G., and Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158 (1997) 2723-2730
36. Singh K.K., Zhang X., Patibandla A.S., Chien Jr. P., and Laal S. Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences. Infect. Immun. 69 (2001) 4185-4191
37. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., Ganz T., Thoma-Uszynski S., Melian A., Bogdan C., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282 (1998) 121-125
38. Talaat A.M., Lyons R., Howard S.T., and Johnston S.A. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4602-4607
39. Varshavsky A. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12142-12149
40. Voskuil M.I., Schnappinger D., Rutherford R., Liu Y., and Schoolnik G.K. Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinburgh) 84 (2004) 256-262
41. Yin Y., Manoury B., and Fahraeus R. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301 (2003) 1371-1374
42. Zhang G.L., Srinivasan K.N., Veeramani A., August J.T., and Brusic V. PREDBALB/c: a system for the prediction of peptide binding to H2d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res. 33 (2005) W180-W183